Doximity faces flat growth, competitive pressure, and overvaluation, making it a potential short with a $45 target. Click ...

Alabama‘s Tommy Tuberville trades more stocks than any other member of the U.S. Senate, finding himself on lists of top ...

Under the terms of the agreement, Septerna is eligible to receive around $2.2 billion from Novo Nordisk, including more than $200 million in upfront and near-term milestone payments.

Q1 2025 Earnings Call Transcript May 7, 2025 Operator: Hello and welcome to Mirum Pharmaceuticals Reports First Quarter 2025 ...

Q2 2025 Earnings Call Transcript May 12, 2025 Arrowhead Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $2 ...

Danish pharmaceutical company Novo Nordisk has signed a collaboration deal with U.S. biotech Septerna that will see the two companies develop pills to treat obesity, type 2 diabetes and other ...

Kirkpatrick noted that the company continues to work on the development of its lead product, PF614, an extended-release oxycodone to treat severe pain, as well as its combination product, PF614-MPAR, ...

Shares of Xenon Pharmaceuticals Inc. (NASDAQ:XENE) were trading at $30.25, down $5.60, or 15%, on word of the delay of data from the phase III X-tole2 trial with azetukalner in focal onset seizures ...

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products ...

Global pharmaceutical shares jumped in intraday trading Monday, reversing their pre-market declines, as investors anticipated ...

Collegium Pharmaceutical (COLL) said it has entered into an accelerated share repurchase agreement ((ASR)) with Jefferies to buy back $25 million of its stock.

The company has shown its revolutionary technology can deliver life-changing therapies. Now, it's about whether CRISPR ...